Topic resource collection
Approved comparison material connected to this topic.
774 resourcesRead both sides
BPC-157 NOS stabilization, VEGF upregulation, cytokine modulation Acute injury resolution (0–14 days post-injury) 250–500 mcg SC twice daily 30+ preclinical studies; no human RCTs Best choice for acute traumatic injury and ligame…
Before choosing a peptide protocol, understand that the evidence base varies dramatically. What follows is a structured comparison of the compounds with published data. CJC-1295 + Ipamorelin GHRH agonist + ghrelin mimetic. Synerg…
MK 677 (Ibutamoren) Ghrelin receptor agonist. Stimulates continuous GH release 12.5–25mg daily Once daily (oral or subcutaneous) 15–25% increase in free testosterone over 8–12 weeks in clinical trials Best for sustained GH elevat…
Thymosin Alpha-1 TLR9 receptor activation in dendritic cells IL-12 upregulation → Th1 differentiation Phase III (adjuvant oncology) 42% increase in objective response rate when combined with checkpoint inhibitors Most evidence-ba…
Thymalin HPA axis modulation, cortisol reduction Hypothalamic glucocorticoid feedback Int J Immunopharmacol (cortisol reduction 22–28% over 8 weeks); pilot study showed anagen ratio improvement 58%→74% at 16 weeks 10mg subcutaneo…
Thymalin T-cell receptor modulation, reduces IL-6/TNF-alpha hepatic inflammation 5–10mg, 2–3x weekly, 4–8 week cycles Rodent NAFLD models show 41% reduction in inflammatory infiltrates (Molecular Medicine Reports, 2023) Best-supp…
BPC-157 VEGF upregulation, angiogenesis in avascular disc tissue, type I collagen synthesis 250–500 mcg daily (7–10 mcg/kg) subcutaneous 8–12 weeks minimum Rodent models published; human trials limited to case reports Strongest m…
BPC-157 FAK-paxillin activation, VEGF upregulation 200–500 mcg daily High. Stimulates new capillary formation in ischemic zones Moderate. Reduces chronic inflammation markers Best first-line peptide for acute tendon injuries; fas…
BPC-157 Upregulates VEGF and FAK-paxillin pathway; enhances fibroblast migration and collagen synthesis Inflammatory + Proliferative (weeks 0–6) 250–500 mcg/day subcutaneous 4–8 weeks Most evidence-supported for tendon-to-bone in…
BPC-157 VEGF/FGF-2 upregulation; FAK-paxillin pathway activation 30–50% faster callus formation; improved bone mineral density; enhanced angiogenesis 10 g/kg to 10 mg/kg (animal); human data absent Often marketed as 'heals everyt…
CJC-1295 (no DAC) + Ipamorelin GHRH analog + ghrelin agonist (pulsatile GH release) 70–85% above baseline 2–3× daily No desensitisation Multiple trials show 4–6% lean mass gain over 12–16 weeks Gold standard for bulking. Mimics n…
Thymalin Restores T-cell differentiation blocked by cortisol mistiming Immune (thymus) 10 mg SC daily × 5–10 days 2–3 hours Addresses immune suppression. Not cognitive symptoms Cerebrolysin Delivers BDNF and NGF to enhance hippoc…
GHK-Cu Copper chelation, MMP modulation, collagen remodeling Topical 2–3mg/mL twice daily 12% increase in follicle density, 18% increase in shaft diameter (24 weeks, Dermatologic Therapy 2023) Best for localized androgenetic alop…
BPC-157 VEGF upregulation, collagen type I synthesis, FAK-paxillin pathway activation Tendons, ligaments, fibrocartilage Rodent tendon studies show 30–40% faster healing at 14 days vs controls 200–500 mcg/day subcutaneous or loca…
Thymosin Beta-4 Blocks RORγt transcription factor, reducing Th17 differentiation IL-23/IL-17 axis upstream 5–10mg SC twice weekly ~2 hours Animal models + Phase 1 human trials (wound healing) BPC-157 Modulates FGF receptors, norm…
Thymalin Thymic immune restoration; upregulates OGG1, XRCC1 Base excision repair (BER) + immune surveillance 35–40% thymic mass restoration in aged rats (Biogerontology, 2018); increased DNA repair gene expression Subcutaneous in…
Before selecting peptides for OTS recovery, understand how each compound's mechanism aligns with your specific dysregulation pattern. Immune suppression, inflammatory persistence, or autonomic imbalance. BPC-157 NO pathway modula…
BPC-157 Promotes angiogenesis, modulates NF-κB inflammation signaling, accelerates collagen synthesis in tendons and ligaments Rodent tendon injury models showed 40–60% faster healing; human data limited to case reports 200–500 m…
Growth Hormone Secretagogues (MK 677, CJC-1295/Ipamorelin) Amplify pulsatile GH release → elevate IGF-1 → improve follicle maturation and Leydig cell function Pituitary gland, ovarian granulosa cells, testicular Leydig cells 12.5…
Tendon/ligament repair (Achilles, plantar fascia, IT band) Upregulates VEGF and growth factors; promotes angiogenesis and tendon-to-bone healing 200–500 mcg/day subcutaneous 2–4 weeks for noticeable improvement in animal studies …